Service expected to offer insights to sponsors conducting clinical trials in any indication in under ten days.
Phesi, a patient-centric data software and service provider, has officially launched its new health check and trial rescue service. The service works by leveraging Phesi’s AI-driven trial accelerator platform to assess protocols in terms of patient view, country view, site view and investigator view. Reportedly, the free of charge service will enable sponsors to submit their protocols to Phesi for a review, offering real-time insights and forecasting within ten working days.
“The clinical trials industry is facing a chronic challenge,” stated Gen Li, PhD, CEO, founder, Phesi. “Once a trial is underway, sponsors are often forced to amend the protocol to better align with the targeted patient population, often with millions of dollars on the line. Further, we know around a fifth of trials designed today will fail and that many “zombie” trials continue to run, mostly caused by inadequate protocol design. Phesi’s new Health Check and Trial Rescue Service addresses these issues by conquering two evergreen challenges: too many protocol amendments and too many failures to complete enrolment as planned. With this service, sponsors can take a proactive, data-driven approach – they won’t need to wait until a study is at risk of failing before they take action.”
Reference: Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster. PharmiWeb. October 13, 2023. Accessed October 13, 2023. https://www.pharmiweb.com/press-release/2023-10-13/phesi-launches-health-check-and-trial-rescue-service-to-save-at-risk-trials-and-bring-drugs-to-market-faster#:~:text=Phesi's%20Health%20Check%20and%20Trial,trial%20planning%20and%20execution%20process
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.